Multi-institutional randomized phase 2 trial of the combination chemotherapy of carboplatin and pemetrexed for advanced nonsquamous non-small-cell lung cancer
Not Applicable
- Conditions
- onsquamous non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000008842
- Lead Sponsor
- Kansai Clinical Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Squamous cell carcinoma 2.Irradiation for praimary lesion 3.SVC syndrome 4.Uncontrollable pleural effusion 5.Massive ascites or pericardial efusion 6.Interstitial pneumonia revealed by chestXP 7.Symptomatic brain metastasis 8.Untreated double cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method One year survival and safety